182,479 abrdn Healthcare Investors $HQH Shares Sold by Wedbush Securities Inc.

Key Points

• Wedbush Securities cut its abrdn Healthcare Investors stake by 78% in the third quarter, selling 182,479 shares and retaining 51,403 shares valued at approximately $1.07 million.
• Institutional investors own 32.6% of HQH, while several funds—including Triumph Capital Management, Concorde Asset Management and Ashton Thomas Securities—modestly increased their positions.
• HQH opened at $20.27 and recently declared a quarterly dividend of $0.66, equal to an annualized $2.64 payout and a 13.0% dividend yield.

Wedbush Securities Inc. reduced its stake in abrdn Healthcare Investors (NYSE:HQH - Free Report) by 78.0% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 51,403 shares of the financial services provider's stock after selling 182,479 shares during the period. Wedbush Securities Inc. owned 0.09% of abrdn Healthcare Investors worth $1,074,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Triumph Capital Management increased its holdings in abrdn Healthcare Investors by 1.3% in the second quarter. Triumph Capital Management now owns 45,512 shares of the financial services provider's stock valued at $1,000,000 after purchasing an additional 567 shares during the last quarter. Concorde Asset Management LLC lifted its stake in abrdn Healthcare Investors by 6.3% in the first quarter. Concorde Asset Management LLC now owns 11,487 shares of the financial services provider's stock valued at $204,000 after buying an additional 676 shares during the period. Ashton Thomas Securities LLC boosted its holdings in abrdn Healthcare Investors by 6.5% during the first quarter. Ashton Thomas Securities LLC now owns 11,592 shares of the financial services provider's stock worth $206,000 after buying an additional 712 shares during the last quarter. Bollard Group LLC bought a new position in abrdn Healthcare Investors during the first quarter worth about $25,000. Finally, Royal Bank of Canada boosted its holdings in abrdn Healthcare Investors by 0.5% during the first quarter. Royal Bank of Canada now owns 519,667 shares of the financial services provider's stock worth $9,245,000 after buying an additional 2,582 shares during the last quarter. 32.60% of the stock is currently owned by institutional investors.

abrdn Healthcare Investors Stock Performance

abrdn Healthcare Investors stock opened at $20.27 on Monday. abrdn Healthcare Investors has a 1 year low of $17.14 and a 1 year high of $24.85. The business has a 50-day moving average of $21.47 and a 200-day moving average of $20.88.

abrdn Healthcare Investors Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, September 30th. Investors of record on Monday, August 24th were given a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 13.0%. The ex-dividend date was Monday, August 24th.

abrdn Healthcare Investors Company Profile

abrdn Healthcare Investors NYSE: HQH is a non-diversified, closed-end investment company focused on the global healthcare and life sciences industries. Rather than operating healthcare businesses directly, the fund invests in the securities of companies involved in areas such as pharmaceuticals, biotechnology, medical devices, healthcare services and related technologies.

The fund seeks long-term capital appreciation, with current income as a secondary objective. Its portfolio may include common and preferred stocks, convertible securities and other investments issued by healthcare companies at various stages of development.

Want to see what other hedge funds are holding HQH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for abrdn Healthcare Investors (NYSE:HQH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.